当前位置:首页 - 行情中心 - 君实生物-U(688180) - 财务分析

君实生物-U

(688180)

  

流通市值:200.01亿  总市值:257.86亿
流通股本:7.65亿   总股本:9.86亿

君实生物-U(688180)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-9.89亿元,每股收益-0.94元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益627994.05万元,未分配利润-998683.53万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1085761.35万元,负债457767.31万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入1,271,200,009.95786,056,275.43380,804,271.071,502,549,915.75
营业总成本2,261,152,311.321,434,750,281.6703,379,531.63,811,859,509.4
营业利润-969,121,005.27-675,685,390.06-292,835,633.87-2,457,442,353.76
利润总额-984,644,050.09-684,157,875.98-296,549,370.19-2,491,694,600.59
净利润-988,725,690.94-687,709,041.49-299,647,965.46-2,535,689,297.85
其他综合收益-47,944,698.9-24,342,498.84852,568.88-73,658,461.53
综合收益总额-1,036,670,389.84-712,051,540.33-298,795,396.58-2,609,347,759.38
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计4,585,525,675.864,820,896,908.346,193,826,374.395,571,075,088.71
非流动资产合计6,272,087,848.846,168,116,553.275,830,659,422.15,771,791,782.62
资产总计10,857,613,524.710,989,013,461.6112,024,485,796.4911,342,866,871.33
流动负债合计2,296,970,306.442,286,205,148.622,968,373,024.382,438,397,575.55
非流动负债合计2,280,702,743.872,098,250,555.342,037,298,573.581,583,858,823.8
负债合计4,577,673,050.314,384,455,703.965,005,671,597.964,022,256,399.35
归属于母公司股东权益合计6,172,509,756.396,477,925,830.396,866,046,795.727,151,224,186.47
股东权益合计6,279,940,474.396,604,557,757.657,018,814,198.537,320,610,471.98
负债和股东权益合计10,857,613,524.710,989,013,461.6112,024,485,796.4911,342,866,871.33
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计1,396,882,602.67867,131,013.12399,332,111.781,741,533,154.58
经营活动现金流出小计2,510,354,687.281,732,482,684.72775,909,983.63,746,515,251.55
经营活动产生的现金流量净额-1,113,472,084.61-865,351,671.6-376,577,871.82-2,004,982,096.97
投资活动现金流入小计941,248,272277,237,849.24164,082,716.541,358,391,615.6
投资活动现金流出小计2,024,759,021.671,225,713,348.07237,353,091.52,291,582,521.72
投资活动产生的现金流量净额-1,083,510,749.67-948,475,498.83-73,270,374.96-933,190,906.12
筹资活动现金流入小计1,933,431,848.111,438,269,008.851,278,808,892.921,340,578,673.91
筹资活动现金流出小计1,033,401,651.88695,885,457.7758,970,308.36628,750,893.95
筹资活动产生的现金流量净额900,030,196.23742,383,551.081,219,838,584.56711,827,779.96
汇率变动对现金及现金等价物的影响-6,855,136.194,770,876.491,249,683.87,551,261.18
现金及现金等价物净增加额-1,303,807,774.24-1,066,672,742.86771,240,021.58-2,218,793,961.95
期末现金及现金等价物余额2,474,334,261.642,711,469,293.024,549,382,057.463,778,142,035.88
最新报告期:2025-01-18
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
方正证券周超泽-1.31-0.260.292025-01-18
光大证券吴佳青-0.93-0.390.342024-11-15
中信证券陈竹-1.26-0.270.462024-11-08
国盛证券宋歌,张金洋,胡偌碧-1.18-0.620.222024-11-04
TOP↑